About GlySens
GlySens is a Healthcare company based in San Diego (United States) founded in 1997. Implantable Continuous glucose monitoring device. It operates in the Healthcare and Technology sectors. The company has 29 employees. Its chief executive, as recorded, is William Markle. GlySens offers products and services including Breakfast Menu, Salads, and Coneys. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Diabetes Monitoring. Its legal entity is GLYSENS INCORPORATED. Its competitors include Dexcom, Livongo and One Drop; 3 of its 3 listed competitors have raised funding.
Company details
GlySens Incorporated was founded in 1997 in San Diego, United States, within the biomedical technology sector. Implantable sensors for continuous glucose monitoring are produced, offering real-time blood glucose readings, historical data charts, adjustable alerts for hypo- and hyperglycemic events, and onboard storage. Wireless connections to external receivers are enabled, with preclinical trials indicating sensor lifetimes of up to 18 months. Operations focus on diabetes management solutions.
- Headquarters San Diego, United States
- Employees 29
- SectorsHealthcareTechnology
- Website glysens.com
- Legal Name Glysens Incorporated
- Latest Funding Round$15M (USD), Unspecified
Jun 2020
- InvestorsHHS
& 4 more
- Employee Count29
Products & Services of GlySens
GlySens offers a comprehensive portfolio of products and services, including Breakfast Menu, Salads, and Coneys.
Provides various breakfast items for morning dining
Offers fresh salad options as healthy meal choices
Specializes in coney-style hot dogs and related items
Funding Insights of GlySens
- Total Rounds 9
- Last Round Unspecified — $15M
- First Round $5.72M
(Jun 2007)
- Investors Count 5
All 9 funding rounds of GlySens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $15M | Unspecified | – | McNair, Fayez Sarofim | – |
| Dec 2015 | $20M | Unspecified | – | – | – |
| Jan 2015 | $12M | Unspecified | – | – | – |
| Nov 2014 | $2M | Grant | – | – | |
| Sep 2014 | $225,000 | Grant | – | – | |
| Sep 2012 | Unspecified | – | – | ||
| Sep 2009 | $5.22M | Grant | – | – | |
| May 2008 | $499,460 | Grant | – | – | |
| Jun 2007 | $5.72M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in GlySens
GlySens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, McNair Interests and Fayez Sarofim.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment services are offered by McNair Interests in Houston. | mcnair.com | Houston, United States | ||
Global private equity investments are managed from Houston. | sarofim.com | Houston, United States | ||
Research and health information on diabetes and kidney diseases are provided by NIDDK. | 1950 | niddk.nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
West Health is focused on improving aging and healthcare for seniors in America. | westhealth.org | La Jolla, United States |
Investor details for GlySens
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GlySens
14 people are tracked at GlySens (5 in leadership, 8 in board & advisors, 1 in team); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
William Markle | CEO | Leadership |
Don Healy | VP, Manufacturing | Leadership |
Ted Williams | VP, Regulatory Affairs & Quality Assurance | Leadership |
Tim L. Routh | VP, Product Development | Leadership |
William H. Markle | CEO & President | Leadership |
Bruce Buckingham | Medical Advisor | Board & advisors |
Adam E. Fine | Director | Board & advisors |
Orville G. Kolterman | Director | Board & advisors |
Richard P. Thompson | Director | Board & advisors |
Daniel P. Connally | Director | Board & advisors |
Robert L. Engler | Director | Board & advisors |
R. Cary Mcnair | Director | Board & advisors |
Daniel Einhorn | Medical Advisor | Board & advisors |
William Choi | Development Engineering Manager | Team |
Complete people profiles for GlySens
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GlySens
3 dated milestones of GlySens across 23 years, from founding to its latest funding, stage changes and deals.
- Founded GlySens is founded.
- Funding First funding round of $5.7M.
- Funding Latest funding round, Unspecified, of $15.0M.
Competitors of GlySens
GlySens has 3 listed competitors in our database, 3 of them funded. They include Dexcom, Livongo and One Drop.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $237M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions |
Detailed competitors of GlySens
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GlySens
Websites that share an audience with GlySens (glysens.com).
Websites whose visitors overlap most with GlySens. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mobihealthnews.com | 100% | 133.6K | #351,855 | View details | |
| impella.com | 80% | 164.3K | #136,622 | View details |
Top companies in Diabetes
3 companies that operate in the same segment as GlySens (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Glysens
Complete news archive for GlySens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GlySens
GlySens was founded in 1997 and raised its 1st funding round 10 years after it was founded.
GlySens is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
William Markle is the CEO of GlySens, as recorded in our data.
GlySens has 29 employees.
GlySens Incorporated was founded in 1997 in San Diego, United States, within the biomedical technology sector. Implantable sensors for continuous glucose monitoring are produced, offering real-time blood glucose readings, historical data charts, adjustable alerts for hypo- and hyperglycemic events, and onboard storage. Wireless connections to external receivers are enabled, with preclinical trials indicating sensor lifetimes of up to 18 months. Operations focus on diabetes management solutions.
GlySens offers Breakfast Menu, Salads, and Coneys.
GlySens has 5 investors. Key investors include HHS, McNair Interests, Fayez Sarofim, National Institute of Diabetes and Digestive and Kidney Diseases, and West Health.
GlySens operates through Glysens Incorporated.